Source: European Medicines Agency (EU) Revision Year: 2023 Publisher: Plusultra pharma GmbH, Fritz-Vomfelde-Str. 36, 40547 Düsseldorf, Germany
Hyftor 2 mg/g gel.
| Pharmaceutical Form |
|---|
|
Gel. Colourless transparent gel. |
Each gram of gel contains 2 mg of sirolimus.
Excipient with known effect: Each gram of gel contains 458 mg of ethanol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Sirolimus |
Sirolimus inhibits T-cell activation induced by most stimuli, by blocking calcium-dependent and calcium-independent intracellular signal transduction. Studies demonstrated that its effects are mediated by a mechanism that is different from that of ciclosporin, tacrolimus, and other immunosuppressive agents. |
| List of Excipients |
|---|
|
Carbomer |
Aluminium tube with high density polyethylene closure.
Pack size: 1 tube containing 10 g of gel.
Plusultra pharma GmbH, Fritz-Vomfelde-Str. 36, 40547 Düsseldorf, Germany
EU/1/23/1723/001
| Drug | Countries | |
|---|---|---|
| HYFTOR | Austria, Estonia, Ireland, Italy, Lithuania, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
